Pharma in review: trending stories 12/6/19
Most popular Pharma Manufacturing stories from the past seven days. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 6, 2019 Category: Pharmaceuticals Source Type: news
FDA approves first generics of Novartis blockbuster MS drug
The U.S. FDA has approved three applications for first generics of Gilenya capsules for the treatment of relapsing forms of multiple sclerosis in adults. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 6, 2019 Category: Pharmaceuticals Source Type: news
The next decade of cleanrooms
Pre-fab and modular cleanrooms are on the rise, but stick-built
still dominate. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 6, 2019 Category: Pharmaceuticals Source Type: news
Novartis partners with Amazon to boost manufacturing efficiency
Novartis will work with Amazon ’s cloud-computing unit, Amazon Web Services, to make the manufacturing and delivery of new medicines more efficient. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 6, 2019 Category: Pharmaceuticals Source Type: news
Moving beyond the last frontier of paper
Hear the current regulatory perspective on digitalization and what that means for pharma from a former FDA auditor (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 6, 2019 Category: Pharmaceuticals Source Type: news
Pharma's struggle to find balance
Other manufacturing sectors, such as automotive, food and electronics, have long used automated technology in their factories. However, it has been difficult for the pharmaceutical industry to implement automation and other industrial technologies on quite the same scale. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 5, 2019 Category: Pharmaceuticals Source Type: news
EMA asks pharma to test diabetes drugs for NDMA
Common diabetes drugs have become the newest target of an ongoing NDMA scare in pharma. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 5, 2019 Category: Pharmaceuticals Source Type: news
Merck spars with insurers over $1.3B cyberattack
Merck says that the attack wiped out years of research data, hampered work at facilities and cost the company $1.3 billion in damages. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 5, 2019 Category: Pharmaceuticals Source Type: news
The future of cold chain logistics
Coming to a supply chain near you (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 3, 2019 Category: Pharmaceuticals Source Type: news
Biocon and Mylan nab FDA approval for Herceptin biosim
Co-developed by both companies, Ogivri will be used for the treatment of breast and gastric cancer patients. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 3, 2019 Category: Pharmaceuticals Source Type: news
AstraZeneca sells more Seroquel rights to Cheplapharm for $42 million
Cheplapharm now adds the rights in United States and Canada to its recently acquired ones for Seroquel and Seroquel XR in most European markets and Russia. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 3, 2019 Category: Pharmaceuticals Source Type: news
FDA denies Lexicon appeal of drug rejection
Lexicon Pharmaceuticals has failed in its efforts to appeal a rejection from the FDA for its diabetes drug, Zynquista. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 3, 2019 Category: Pharmaceuticals Source Type: news
Astellas to shell out $3 billion in gene therapy takeover
Japan-based Astellas Pharma is dropping nearly $3 billion in cash to scoop up San Francisco ’s Audentes Therapeutics. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 3, 2019 Category: Pharmaceuticals Source Type: news
The crux of an effective pharma recall
Pharma can take steps now to prepare for the interconnected, digital supply chain (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 2, 2019 Category: Pharmaceuticals Source Type: news
Samoan government shuts down over measles outbreak
The Samoan government will shut down for two days as part of a series of drastic steps being taken to stop a deadly outbreak of measles. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 2, 2019 Category: Pharmaceuticals Source Type: news
